Screening and identification analysis of serum protein biomarkers in nephroblastoma

Jia-xiang WANG,Shao-bo YANG,Qiu-liang LIU,Rui DONG,Yu-xia FAN,Qian ZHANG,Fu-quan YANG,Peng WU,Jie-kai YU,Shu ZHENG
DOI: https://doi.org/10.3760/cma.j.issn.0376-2491.2009.18.011
2009-01-01
Abstract:Objective To screen and characterize the serum protein biomarkers in nephroblastoma so as to establish the proteins as the specific serum biomarkers for diagnosis and prognosis monitoring.Methods The differential protein peaks were located by detecting serum samples of preoperative and postoperative patients and normal children using the SELDI-TOF MS technology.After purification,the differential proteins were further analyzed by LC-MS/MS and the protein sequences searched in database.Results Two peaks with m/z of 6455.5 and 6984.4 were selected as potential biomarkers.They were weakly expressed in nephroblastoma(intensity:1029 ± 364,297 ± 126)but highly expressed in normal individuals(2108 ± 837,753 ± 226);another peak with m/z of 9190.8 was weakly expressed in preoperative sera(283 ± 154) but highly expressed in serum samples of postoperative patients and normal children(5974 ± 657,6231 ±519).The protein at 6455.5 and 9190.8 were identified as apolipoprotein C-Ⅲ and haptogloblin respectively.Conclusion The detection of differentially expressed apolipoprotein C-Ⅲ and haptogloblin may have potential utilities for serum diagnosis,malignancy classification and prognosis monitoring of nephroblastoma and is worthy of further studies and applications.
What problem does this paper attempt to address?